Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy

Radiotherapy and Oncology

Volumn 94, Issue 1, 2010, Pages 12-23

  Polo, Alfredo ^a   Salembier, Carl ^b   Venselaar, Jack ^c   Hoskin, Peter ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Europe Hospitals ^*  (Belgium)

^c DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^d MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

CT; Dosimetry; Intraoperative planning; MR; Prostate brachytherapy; Ultrasound

Indexed keywords

CONE BEAM COMPUTED TOMOGRAPHY; DOSE CALCULATION; DOSIMETRY; FEEDBACK SYSTEM; FLUOROSCOPY; HUMAN; IMAGING; INTRAOPERATIVE PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; ROBOTICS; SYSTEMATIC REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

BRACHYTHERAPY; HUMANS; INTRAOPERATIVE PERIOD; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 74549115327     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.12.012     Document Type: Review

References (84)

1. Goharderakhshan R.Z., Grossfeld G.D., Kassis A., Shinohara K., Roach M., and Carroll P.R. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology 56 (2000) 622-626
2. Hinnen K.A., Jan J.B., van Roermund J.G., et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys (2009)
3. Sahgal A., and Roach Mr. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application. Nat Clin Pract Urol 4 (2007) 658-670
4. Yu Y., Anderson L.L., Li Z., et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine task group no. 64. Med Phys 26 (1999) 2054-2076
5. Holm H.H., Juul N., Pedersen J.F., Hansen H., and Stroyer I. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130 (1983) 283-286
6. Blasko J.C., Grimm P.D., and Ragde H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol 3 (1993) 240-249
7. Grimm P.D., Blasko J.C., Sylvester J.E., Meier R.M., and Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 31-40
8. Ragde H., Korb L.J., Elgamal A.A., Grado G.L., and Nadir B.S. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 89 (2000) 135-141
9. Lee W.R., Moughan J., Owen J.B., and Zelefsky M.J. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer 98 (2003) 1987-1994
10. Prestidge B.R., Prete J.J., Buchholz T.A., et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 40 (1998) 461-465
11. Kaplan I.D., Holupka E.J., Meskell P., et al. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology 56 (2000) 492-495
12. Messing E.M., Zhang J.B., Rubens D.J., et al. Intraoperative optimized inverse planning for prostate brachytherapy: early experience. Int J Radiat Oncol Biol Phys 44 (1999) 801-808
13. Beaulieu L., Evans D.A., Aubin S., et al. Bypassing the learning curve in permanent seed implants using state-of-the-art technology. Int J Radiat Oncol Biol Phys 67 (2007) 71-77
14. Nag S., Ciezki J.P., Cormack R., et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 51 (2001) 1422-1430
15. Vicini F.A., Kestin L.L., and Martinez A.A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 553-561
16. Beyer D.C., Shapiro R.H., and Puente F. Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study. Int J Radiat Oncol Biol Phys 48 (2000) 1583-1589
17. Wilkinson D.A., Lee E.J., Ciezki J.P., et al. Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1241-1244
18. Gewanter R.M., Wuu C., Laguna J.L., Katz A.E., and Ennis R.D. Intraoperative preplanning for transperineal ultrasound-guided permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 377-380
19. Matzkin H., Kaver I., Stenger A., Agai R., Esna N., and Chen J. Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning. Urology 62 (2003) 497-502
20. Woolsey J., Bissonette E., Schneider B.F., and Theodorescu D. Prospective outcomes associated with migration from preoperative to intraoperative planned brachytherapy: a single center report. J Urol 172 (2004) 2528-2531
21. Shah J.N., Wuu C.S., Katz A.E., Laguna J.L., Benson M.C., and Ennis R.D. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer J. 12 (2006) 289-297
22. Grado G.L. Techniques to achieve optimal seed placement in salvage and primary brachytherapy for prostate cancer. Tech Urol 6 (2000) 157-165
23. Grado G.L., Larson T.R., Balch C.S., et al. Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 42 (1998) 289-298
24. Shanahan T.G., Nanavati P.J., Mueller P.W., and Maxey R.B. A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys 53 (2002) 490-496
25. Zelefsky M.J., Yamada Y., Cohen G., et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys 48 (2000) 601-608
26. Raben A., Chen H., Grebler A., et al. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose. Int J Radiat Oncol Biol Phys 60 (2004) 1631-1638
27. Potters L., Calugaru E., Jassal A., and Presser J. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?. Int J Radiat Oncol Biol Phys 65 (2006) 1014-1019
28. Stock R.G., Stone N.N., and Lo Y.C. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant. Tech Urol 6 (2000) 95-98
29. Stock R.G., Stone N.N., Wesson M.F., and DeWyngaert J.K. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32 (1995) 219-225
30. Todor D.A., Zaider M., Cohen G.N., Worman M.F., and Zelefsky M.J. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 48 (2003) 1153-1171
31. Lee E.K., and Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys 56 (2003) 854-861
32. Jain A.K., Zhou Y., Mustufa T., Burdette E.C., Chirikjian G.S., and Fichtinger G. Matching and reconstruction of brachytherapy seeds using the Hungarian algorithm (MARSHAL). Med Phys 32 (2005) 3475-3492
33. Han B.H., Wallner K., Merrick G., Butler W., Sutlief S., and Sylvester J. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys 30 (2003) 898-900
34. Xue J., Waterman F., Handler J., and Gressen E. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 62 (2005) 912-919
35. Meijer G.J., van den Berg H.A., Hurkmans C.W., Stijns P.E., and Weterings J.H. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy. Radiother Oncol 80 (2006) 378-384
36. Su Y, Davis BJ, Herman MG, Robb RA. TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. In: al. JDWe, editor. 14. IOS Press; 2006. p. 532-537.
37. Su Y., Davis B.J., Furutani K.M., Herman M.G., and Robb R.A. Seed localization and TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. Comput Aided Surg 12 (2007) 25-34
38. French D., Morris J., Keyes M., Goksel O., and Salcudean S. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy. Acad Radiol 12 (2005) 1262-1272
39. Gong L., Cho P.S., Han B.H., et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 54 (2002) 1322-1330
40. Su Y., Davis B.J., Herman M.G., and Robb R.A. Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem. Med Phys 31 (2004) 1277-1287
41. Siewerdsen J.H., Moseley D.J., Burch S., et al. Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys 32 (2005) 241-254
42. Jaffray D.A., Siewerdsen J.H., Edmundson G.K., and Wong J.W. Flat-panel cone-beam CT on a mobile isocentric C-arm for image-guided brachytherapy. Proc SPIE 4682 (2002) 209-217
43. Siewerdsen J.H., Daly M.J., Bachar G., and Moseley D.J. Multimode C-arm fluoroscopy, tomosynthesis, and cone-beam CT for image-guided interventions: from proof of principle to patient protocols. Proc SPIE 6510 (2007) 65101A-651011
44. Westendorp H., Hoekstra C.J., van't Riet A., Minken A.W., and Immerzeel J.J. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry. Brachytherapy 6 (2007) 231-237
45. Blumenfeld P., Hata N., DiMaio S., et al. Transperineal prostate biopsy under magnetic resonance image guidance. A needle placement accuracy study. J Magn Reson Imaging 26 (2007) 688-694
46. Cormack R.A., D'Amico A.V., Hata N., Silverman S., Weinstein M., and Tempany C.M. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology 56 (2000) 663-664
47. Aigner F., Pallwein L., Pelzer A., et al. Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol 25 (2007) 351-359
48. Shukla-Dave A., Hricak H., Kattan M.W., et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int 99 (2007) 786-793
49. Clarke D.H., Banks S.J., Wiederhorn A.R., et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int J Radiat Oncol Biol Phys 52 (2002) 903-910
50. De Meerleer G., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 75 (2005) 325-333
51. Tanaka O., Hayashi S., Matsuo M., et al. MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol 2 (2007) 2
52. Tempany C., Straus S., Hata N., and Haker S. MR-guided prostate interventions. J Magn Reson Imaging 27 (2008) 356-367
53. Van Gellekom M.P., Moerland M.A., Battermann J.J., and Lagendijk J.J. MRI-guided prostate brachytherapy with single needle method - a planning study. Radiother Oncol 71 (2004) 327-332
54. Hricak H., Jeffrey R.B., Dooms G.C., and Tanagho E.A. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol 9 (1987) 1-8
55. Terris M.K., and Stamey T.A. Determination of prostate volume by transrectal ultrasound. J Urol 145 (1991) 984-987
56. Rahmouni A., Yang A., Tempany C.M., et al. Accuracy of in vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 16 (1992) 935-940
57. Terris M.K., McNeal J.E., and Stamey T.A. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 147 (1992) 855-857
58. al-Rimawi M., Griffiths D.J., Boake R.C., Mador D.R., and Johnson M.A. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol 74 (1994) 596-600
59. Tewari A., Indudhara R., Shinohara K., et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound 24 (1996) 169-174
60. Sosna J., Rofsky N.M., Gaston S.M., DeWolf W.C., and Lenkinski R.E. Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. Acad Radiol 10 (2003) 846-853
61. van As N., Parker C., and de Souza N. Magnetic resonance imaging is the modality of choice for accurate assessment of prostate volume. Clin Oncol 19 (2007) S4
62. Penner E.A. Interventional MR with a mid-field open system. In: Debatin JFA G. (Ed). Interventional magnetic resonance imaging (1998), Springer-Verlag, Berlin 11-18
63. Popowski Y., Hiltbrand E., Joliat D., and Rouzaud M. Open magnetic resonance imaging using titanium-zirconium needles: improved accuracy for interstitial brachytherapy implants?. Int J Radiat Oncol Biol Phys 47 (2000) 759-765
64. Kooy H.M., Cormack R.A., Mathiowitz G., Tempany C., and D'Amico A.V. A software system for interventional magnetic resonance image-guided prostate brachytherapy. Comput Aided Surg 5 (2000) 401-413
65. D'Amico A.V., Cormack R., Tempany C.M., et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 507-515
66. D'Amico A., Cormack R., Kumar S., and Tempany C.M. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 14 (2000) 367-370
67. D'amico A.V., Tempany C.M., Schultz D., et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology 62 (2003) 1063-1067
68. Landis D.M., Schultz D., Cormack R., et al. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology 65 (2005) 750-754
69. Thomas M.D., Cormack R., Tempany C.M., et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 47 (2000) 905-908
70. Nguyen P.L., Chen M.H., D'Amico A.V., et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110 (2007) 1485-1492
71. Ficarra V., Cavalleri S., Novara G., Aragona M., and Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol. 51 (2007) 45-55 discussion 56
72. Wei Z., Wan G., Gardi L., Mills G., Downey D., and Fenster A. Robot-assisted 3D-TRUS guided prostate brachytherapy: system integration and validation. Med Phys 31 (2004) 539-548
73. Fichtinger G., Fiene J.P., Kennedy C.W., et al. Robotic assistance for ultrasound-guided prostate brachytherapy. Med Image Anal 12 (2008) 535-545
74. Davies B.L., Harris S.J., and Dibble E. Brachytherapy - an example of a urological minimally invasive robotic procedure. Int J Med Robot 1 (2004) 88-96
75. Lagerburg V., Moerland M.A., van Vulpen M., and Lagendijk J.J. A new robotic needle insertion method to minimise attendant prostate motion. Radiother Oncol 80 (2006) 73-77
76. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
77. Bentzen S.M. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
78. Zelefsky M.J., Cohen G., Zakian K.L., et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J 6 (2000) 249-255
79. Mizowaki T., Cohen G.N., Fung A.Y., and Zaider M. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54 (2002) 1558-1564
80. Hoskin P.J., Carnell D.M., Taylor N.J., et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys 68 (2007) 1065-1071
81. Yamaguchi T., Lee J., Uemura H., et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32 (2005) 742-748
82. Hara T., Kosaka N., and Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39 (1998) 990-995
83. Nakanouchi T., Okihara K., Kojima M., et al. Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer. Urology 58 (2001) 573-577
84. Goossen T.E., de la Rosette J.J., Hulsbergen-van de Kaa C.A., van Leenders G.J., and Wijkstra H. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 43 (2003) 124-131